DEVICE · Unmapped registry intervention
Cardiac Resynchronization Therapy+Implantable Cardioverter Defibrillator
Find medicine records ·
Find other trials using this name
Clinical trial
Clinical Investigation of the Medtronic Concerto™ Device
NCT00268320
Drugs and interventions used in this trial
1 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
No matching interventions in this trial.
Study at a glance
Registry-backedClinical Investigation of the Medtronic Concerto™ Device
Design: INTERVENTIONAL · Status: COMPLETED · Phase: NA
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Interventions
Sponsors & collaborators
Medtronic Cardiac Rhythm and Heart Failurelead sponsor
Mapped research locations
St LouisMissouri, United States1AtlantaGeorgia, United States1NashvilleTennessee, United States1ClevelandOhio, United States1PittsburghPennsylvania, United States1CincinnatiOhio, United States1PhoenixArizona, United States1JacksonvilleFlorida, United States1OrlandoFlorida, United States1Oklahoma CityOklahoma, United States1DetroitMichigan, United States1AustinTexas, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00268320 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.